MHRA Class 3 Medicines Recall: Clonidine hydrochloride 50micrograms/5ml oral solution
MHRA Class 3 Medicines Recall: Clonidine hydrochloride 50micrograms/5ml oral solution
February 17, 2021
Class 3 Medicines recall: Clonidine hydrochloride 50micrograms/5ml oral solution (SyriMed) (previously known as Thame Laboratories Licensed Medicines Division)
Drug alert number: EL (21) A/05
Date issued: 17th February 2021
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for:
Clonidine hydrochloride 50micrograms/5ml oral solution (SyriMed) PL 39307/0082
SyriMed are recalling the below batch as a precautionary measure due to an issue related to the container closure (child-lock cap). The Marketing Authorisation Holder has received a number of complaints related to defective container closures and the investigation has identified an issue with the bottle capping during the manufacturing process for the batch below only.
| Batch Number | Expiry Date | Pack Size | First Distributed |
| 201014 | September 2022 | 100ml | 19th November 2020 |
Advice for healthcare professionals
- Stop supplying the batches listed above immediately.
- Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
Company contacts for further information
For more information or medical information queries, please contact: customer.services@syrimed.co.uk.
Posted in: Dispensing & Supply
